UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 25, 2002
GENESIS HEALTH VENTURES, INC.
----------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Pennsylvania 0-33217 06-1132947
------------ ------- ----------
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation) Identification No.)
101 East State Street,
Kennett Square, Pennsylvania 19348
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (610) 444-6350
Not Applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events
On November 25, 2002, Genesis Health Ventures, Inc. announced financial
results for its fiscal year ended September 30, 2002.
Selected Financial Data of Genesis Health Ventures, Inc.
(Amounts in thousands, except per share data)
(unaudited) Twelve Months Ended
September 30,
2002
-------------------
Statement of Operations Data:
Net revenues........................................................ $ 2,623,679
Income from continuing operations................................... 73,794
Net income attributable to common shareholders...................... 70,167
Per common share data (diluted):
Income from continuing operations .................................. 1.76
Net income attributable to common shareholders...................... $ 1.68
Weighted average shares of common stock and equivalents--
diluted.......................................................... 43,351
Other Financial Data:
Capital expenditures................................................ $ 48,969
(unaudited)
September 30,
2002
-------------------
Balance Sheet Data:
Working capital..................................................... $ 470,310
Total assets........................................................ 1,983,977
Long-term debt...................................................... 675,770
Redeemable preferred stock.......................................... 44,765
Shareholders' equity ............................................... $ 911,601
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GENESIS HEALTH VENTURES, INC.
Date: December 3, 2002 By: /s/ George V. Hager, Jr.
----------------------------------
George V. Hager, Jr.
Executive Vice President and
Chief Financial Officer